Indication
Hypercortisolism
Hypercortisolism is an endocrine disorder characterized by prolonged, inappropriate systemic exposure to excessive levels of glucocorticoids. Read more about Hypercortisolism
6 drugs 3 manufacturers
Drugs that treat it
Common Hypercortisolism therapies.
SIGNIFOR LAR (pasireotide pamoate)
SIGNIFOR (pasireotide diaspartate)
SIGNIFOR (pasireotide diaspartate)
SIGNIFOR LAR (pasireotide pamoate)
SIGNIFOR LAR (pasireotide pamoate)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonHypercortisolism is an endocrine disorder characterized by prolonged, inappropriate systemic exposure to excessive levels of glucocorticoids.
It affects multiple organ systems and can arise from exogenous glucocorticoid administration or endogenous causes, which are further classified as ACTH-dependent (such as pituitary or ectopic ACTH-secreting tumors) or ACTH-independent (such as autonomous adrenal cortical adenomas or hyperplasia).
Pathophysiologically, the sustained excess of circulating cortisol disrupts metabolic, vascular, bone, and immune homeostasis.
Clinically, it manifests as central adiposity, facial plethora, proximal muscle weakness, purple cutaneous striae, osteoporosis, hypertension, and glucose intolerance.
- nih.gov
Hypercortisolism is an endocrine disorder characterized by prolonged, inappropriate systemic exposure to excessive levels of glucocorticoids It affects multiple organ systems and can arise from exogenous glucocorticoid administration or endogenous causes, which are further classified as ACTH-dependent (such as pituitary or ectopic ACTH-secreting tumors) or ACTH-independent (such as autonomous adrenal cortical adenomas or hyperplasia)
- nih.gov
Hypercortisolism is an endocrine disorder characterized by prolonged, inappropriate systemic exposure to excessive levels of glucocorticoids Pathophysiologically, the sustained excess of circulating cortisol disrupts metabolic, vascular, bone, and immune homeostasis Clinically, it manifests as central adiposity, facial plethora, proximal muscle weakness, purple cutaneous striae, osteoporosis, hypertension, and glucose intolerance
- nih.gov
It affects multiple organ systems and can arise from exogenous glucocorticoid administration or endogenous causes, which are further classified as ACTH-dependent (such as pituitary or ectopic ACTH-secreting tumors) or ACTH-independent (such as autonomous adrenal cortical adenomas or hyperplasia)
- nih.gov
Pathophysiologically, the sustained excess of circulating cortisol disrupts metabolic, vascular, bone, and immune homeostasis Clinically, it manifests as central adiposity, facial plethora, proximal muscle weakness, purple cutaneous striae, osteoporosis, hypertension, and glucose intolerance
- nih.gov
Clinically, it manifests as central adiposity, facial plethora, proximal muscle weakness, purple cutaneous striae, osteoporosis, hypertension, and glucose intolerance
Personalize your experience
Follow Hypercortisolism and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.